These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 5913352)

  • 21. Voltage laterality in the EEG of psychiatric patients.
    Serafetinides EA
    Dis Nerv Syst; 1973 Mar; 34(3):190-1. PubMed ID: 4715636
    [No Abstract]   [Full Text] [Related]  

  • 22. Prediction of response to and actual outcome of chlorpromazine treatment in schizophrenic patients.
    Sakurai Y; Takahashi R; Nakahara T; Ikenaga H
    Arch Gen Psychiatry; 1980 Sep; 37(9):1057-62. PubMed ID: 7416905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of chlorpromazine and nortriptyline in patients with schizophrenia.
    Loga S; Curry S; Lader M
    Clin Pharmacokinet; 1981; 6(6):454-62. PubMed ID: 7318304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autonomic reactions in relation to psychotropic drugs.
    Hsu JJ; Yap AT
    Dis Nerv Syst; 1967 May; 28(5):304-10. PubMed ID: 6025269
    [No Abstract]   [Full Text] [Related]  

  • 25. [A preliminary study on the measurements of microelements in the serum of schizophrenics].
    Wang SB
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Aug; 20(4):217-8. PubMed ID: 3126027
    [No Abstract]   [Full Text] [Related]  

  • 26. Maintenance treatment of schizophrenia with long-acting fluphenazine.
    Niturad A; Ciurezu T; Cucu I
    Act Nerv Super (Praha); 1974 Aug; 16(3):167. PubMed ID: 4154028
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative studies of the effects of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit symptoms of paranoid schizophrenia].
    Termińska K; Mrowiec W
    Psychiatr Pol; 1989; 23(1):24-30. PubMed ID: 2573098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical experimentation with desipramine with statistical control].
    Kammerer M; Wartel R; Gurfein L; Weil J; Wysoki V; Gelb F
    Ann Med Psychol (Paris); 1968 Jan; 1(1):109-13. PubMed ID: 4870813
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuroleptic drugs and erythrocyte catechol-O-methyltransferase in schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Biol Psychiatry; 1982 Nov; 17(11):1339-42. PubMed ID: 6129906
    [No Abstract]   [Full Text] [Related]  

  • 30. Two cases of deep vein thrombosis associated with antipsychotic drug use.
    Matsumoto M; Konno T; Tamba K; Abe T; Kato S; Kajii E
    Psychiatry Clin Neurosci; 2004 Aug; 58(4):450-1. PubMed ID: 15298663
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum lipids and lipoproteins in schizophrenic patients receiving major tranquilizers.
    Shafique M; Khan IA; Akhtar MH; Hussain I
    J Pak Med Assoc; 1988 Oct; 38(10):259-61. PubMed ID: 3144603
    [No Abstract]   [Full Text] [Related]  

  • 32. A controlled evaluation of haloperidol, chlorpromazine, and sodium amobarbital: intramuscular short-term use in acute psychotic patients.
    Shopsin B; Hekimian LJ; Gershon S; Floyd A
    Curr Ther Res Clin Exp; 1969 Sep; 11(9):561-73. PubMed ID: 4980886
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of two butyrophenone compounds on acute schizophrenic patients: speculation on the neurophysiologic sites of action.
    Gallant DM; Bishop M; Guerrero-Figueroa R
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:53-60. PubMed ID: 4860981
    [No Abstract]   [Full Text] [Related]  

  • 34. Schizophrenia.
    Lawrie S; McIntosh A; Nadeem Z
    Clin Evid; 2005 Dec; (14):1306-30. PubMed ID: 16620456
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hyponatremia of therapeutic origin. Apropos of a case].
    Assal F; Chauchot F
    Encephale; 1994; 20(5):527-9. PubMed ID: 7828516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Predicting the effect of psychopharmacotherapy in schizophrenic patients].
    Dikiĭ NT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):110-5. PubMed ID: 6121436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia.
    Goodnick PJ; Tong C; Duncavage MB; Meltzer HY
    Biol Psychiatry; 1983 Dec; 18(12):1485-8. PubMed ID: 6140962
    [No Abstract]   [Full Text] [Related]  

  • 38. A double blind controlled study of ECT vs chlorpromazine in schizophrenia.
    Bagadia VN; Abhyankar RR; Doshi J; Pradhan PV; Shah LP
    J Assoc Physicians India; 1983 Oct; 31(10):637-40. PubMed ID: 6671932
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the problem of the general and elective action of psycholeptics in the therapy of schizophrenia].
    Smulevich AB; Golovan' LI; Sokolova ED; Tsutsul'kovskaia MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):246-50. PubMed ID: 5655743
    [No Abstract]   [Full Text] [Related]  

  • 40. [On peculiarities of the clinical picture and course of circular schizophrenia and the effect of active therapy on it].
    Barshteĭn EI; Eryshev OF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(2):256-9. PubMed ID: 6000911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.